Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, $0.0001 par value per share
-
Shares outstanding
-
84,787,696
-
Total 13F shares
-
200,884
-
Share change
-
+159,646
-
Total reported value
-
$230,191
-
Price per share
-
$1.15
-
Number of holders
-
11
-
Value change
-
+$180,602
-
Number of buys
-
7
-
Number of sells
-
2
Institutional Holders of CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) as of Q4 2024
As of 31 Dec 2024 CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 200,884 shares of stock of the company.
Largest 10 holders included HRT FINANCIAL LP, UBS Group AG, CITADEL ADVISORS LLC, IFP Advisors, Inc, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, Yakira Capital Management, Inc., RENAISSANCE TECHNOLOGIES LLC, OSAIC HOLDINGS, INC., and BANK OF AMERICA CORP /DE/.
This table shows 11 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.